journal article·2022-01Open access

Phosphorogenic dipyrrinato-iridium(III) complexes as photosensitizers for photodynamic therapy

A. Prieto-Castañeda, A. Lérida-Viso, E. Avellanal-Zaballa, R. Sola-Llano, J. Bañuelos, A.R. Agarrabeitia, R. Martínez-Máñez, M.J. Ortiz

Dyes and Pigments· Volume 197

Abstract

We have designed and synthesized a family of Ir(III) metal complexes coordinated with two cyclometalated bisfluorophenylpyridine ligands and an ancillary dipyrromethene which is functionalized with a mesityl group (Ir (dipy)-1), an alpha-chloroacetyl ester (Ir(dipy)-2) or a chain containing an ammonium cation (Ir(dipy)-3). The Ir (III) complexes feature a high triplet state population enabling red phosphorescence and efficient singlet oxygen generation. Ir(dipy)-2 and Ir(dipy)-3 are demonstrated to stain cells in both one-photon and two-photon confocal imaging. Moreover, Ir(dipy)-2 and Ir(dipy)-3 produce ROS in cells upon irradiation, inducing cell death by apoptosis. Colocalization studies in SK-Mel-103 cells show that Ir(dipy)-3 is partially accumulated in mitochondria and induces upon irradiation a disruption in their morphology. Overall our studies demonstrate that the prepared Ir(III) act as photosensitizers able to kill cells under irradiation, being suitable candidates for photodynamic therapy applications.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Luminescence and Fluorescent Materials · Advanced Fluorescence Microscopy Techniques · Porphyrin and Phthalocyanine Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (59)

Show source-provided references
1. A history of photodynamic therapy10.1111/j.1445-2197.1991.tb00230.x ↗
2. Finsen · 1901
3. The photodynamic properties of a particular hematoporphyrin derivative10.1001/archderm.1960.01580040026005 ↗
4. Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease10.1016/S0022-5223(19)32560-7 ↗
5. The use of a derivative of hematoporphyrin in tumor detection
6. Photodinamic Therapy in cancer treatment-an update review
7. Features of third generation photosensitizers used in anticancer photodynamic therapy: Review10.1016/j.pdpdt.2020.102091 ↗
8. Non-porphyrin dyes used as photosensitizers in photodynamic therapy10.1016/j.jddst.2020.101979 ↗
9. Conjugated photosensitizers for imaging and PDT in cancer research10.1021/acs.jmedchem.0c00047 ↗
10. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
11. Triplet photosensitizers: from molecular design to applications10.1039/c3cs35531d ↗
12. Transition metal complexes as photosensitisers in one- and two-photon photodynamic therapy10.1016/j.ccr.2018.03.020 ↗
13. Two-photon small-molecule fluorescence-based agents for sensing, imaging, and therapy within biological systems10.1039/D0CS00861C ↗
14. Phosphorescent iridium(iii) complexes: a versatile tool for biosensing and photodynamic therapy10.1039/C8DT00887F ↗
15. Iridium complexes as photoactive center for light harvesting and solar cell applications
16. The novel synthesis of tris-cyclometalated iridium(III) complexes for saturated red organic light-emitting diodes with low efficiency roll-off10.1016/j.dyepig.2021.109360 ↗
17. New phosphorescent iridium(iii) dipyrrinato complexes: synthesis, emission properties and their deep red to near-infrared OLEDs10.1039/D1DT01557E ↗
18. AIE multinuclear Ir(III) complexes for biocompatible organic nanoparticles with highly enhanced photodynamic performance10.1002/advs.201802050 ↗
19. Rational design of iridium–porphyrin conjugates for novel synergistic photodynamic and photothermal therapy anticancer agents10.1039/D1SC00126D ↗
20. Transition metal complexes as photosensitizers for integrated cancer theranostic applications10.1016/j.ccr.2020.213355 ↗
21. AcetylacetonateBODIPY‐Biscyclometalated iridium(III) complexes: effective strategy towards smarter fluorescent photosensitizer agents10.1002/chem.201701347 ↗
22. Electrostatic self-assembled Iridium(III) nano-photosensitizer for selectively disintegrated and mitochondria targeted photodynamic therapy10.1016/j.dyepig.2019.108105 ↗
23. Advances in novel iridium (III) based complexes for anticancer applications: a review10.1016/j.ica.2020.119925 ↗
24. Organelle-targeting metal complexes: from molecular design to bio-applications10.1016/j.ccr.2017.10.022 ↗
25. Recent advances of iridium(III) metallophosphors for health-related applications10.1016/j.ccr.2020.213267 ↗
26. Phosphorescent iridium(III) complexes for anticancer applications10.1002/ejic.202000754 ↗
27. Dipyrrin based metal complexes: reactivity and catalysis10.1039/D0DT00884B ↗
28. Recent developments in dipyrrin based metal complexes: self-assemble nanoarchitectures and materials applications10.1142/S1088424620300025 ↗
29. Intriguing ‘Turn-on’ phosphorescent response in the near infrared region upon fluoride binding: dipyrromethene chelating-based Triarylboryl‒Iridium(III) conjugates10.1016/j.dyepig.2020.108706 ↗
30. DNA binding and anti-cancer activity of redox-active heteroleptic piano-stool Ru(II), Rh(III), and Ir(III) complexes containing 4-(2-methoxypyridyl)phenyldipyrromethene10.1021/ic401662d ↗
31. Efficient dipyrrin-centered phosphorescence at room temperature from bis-cyclometalated iridium(III) dipyrrinato complexes10.1021/ic100633w ↗
32. Excited state properties and energy transfer within dipyrrin‐based Binuclear iridium/platinum Dyads: the effect of ortho‐methylation on the spacer10.1002/chem.201103836 ↗
33. An experimental and theoretical approach to the photophysical properties of some Rh and Ir complexes incorporating the dipyrromethene ligand10.1002/ejic.201201427 ↗
34. Controlling the electronic structures and excited-state characteristics of Dipyrrinatoiridium(III) complexes by an arylborane or an arylamino unit10.1021/acs.inorgchem.9b02184 ↗
35. Dipyrrinato‐Iridium(III) complexes for application in photodynamic therapy and antimicrobial photodynamic inactivation
36. Exploring BODIPY derivatives as singlet oxygen photosensitizers for PDT10.1111/php.13232 ↗
37. Synthesis and InVitroEvaluation of a photosensitizer -BODIPYDerivative for potential photodynamic therapy applications10.1002/asia.201500325 ↗
38. Halogen-containing BODIPY derivatives for photodynamic therapy10.1016/j.dyepig.2018.08.007 ↗
39. Efficient synthesis of aryldipyrromethanes in water and their application in the synthesis of corroles and dipyrromethenes10.3998/ark.5550190.0008.a20 ↗
40. A novel Bodipy-Dipyrrin fluorescent probe: synthesis and recognition behaviour towards Fe (II) and Zn (II)10.1016/j.dyepig.2012.02.006 ↗
41. Excited-state energy-transfer Dynamics in self-assembled triads composed of two porphyrins and an intervening bis(dipyrrinato)metal complex10.1021/ic034559m ↗
42. Tuning iridium(III) phenylpyridine complexes in the “almost blue” region10.1039/B406851C ↗
43. Methylthio BODIPY as standard triplet photosensitizer for singlet oxygen production: a photophysical study10.1039/C9CP03454D ↗
44. Benchmarking density functionals on structural parameters of small-/medium-sized organic molecules10.1021/acs.jctc.5b01144 ↗
45. Photofunctional triplet excited states of cyclometalated Ir(III) complexes: beyond electroluminescence10.1039/c2cs35171d ↗
46. Selectively lighting up two-photon photodynamic activity in mitochondria with AIE-active iridium(III) complexes10.1039/C6CC10015E ↗
47. Dual functions of cyclometalated iridium(III) complexes: AntiMetastasis and lysosome-Damaged photodynamic therapy10.1021/acsami.7b10258 ↗
48. Two-photon photodynamic ablation of tumor cells by mitochondria-targeted iridium(III) complexes in aggregate states10.1039/C7TB00731K ↗
49. BODIPYs revealing lipid droplets as valuable targets for photodynamic theragnosis10.1039/C9CC09397D ↗
50. Substituent effects in BODIPY in live cell imaging10.1002/asia.201601400 ↗
51. A review of the synthetic strategies for the development of BODIPY dyes for conjugation with proteins
52. BODIPY-based fluorescent probes for mitochondria-targeted cell imaging with superior brightness, low cytotoxicity and high photostability10.1016/j.dyepig.2017.03.009 ↗
53. Using substituted cyclometalated quinoxaline ligands to finely tune the luminescence properties of iridium(III) complexes10.1021/ic301853t ↗
54. A mitochondria-targeted photosensitizer showing improved photodynamic therapy effects under hypoxia10.1002/anie.201604130 ↗
55. Fluorescent probes for the selective detection of chemical species inside mitochondria10.1039/C5CC09248E ↗
56. Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy10.1039/C4CC05215C ↗
57. Endoplasmic reticulum-localized iridium(III) complexes as efficient photodynamic therapy agents via protein modifications10.1021/jacs.6b05302 ↗
58. Increasing the triplet lifetime and extending the ground-state absorption of biscyclometalated Ir(iii) complexes for reverse saturable absorption and photodynamic therapy applications10.1039/C6DT02416E ↗
59. Metal complexes for two-photon photodynamic therapy: a cyclometalated iridium complex induces two-photon photosensitization of cancer cells under near-IR light10.1002/chem.201604792 ↗